Sources
Story Timeline
•Latest version
FDA Approves Italfarmaco's Duvyzat for DMD, AbbVie's Elahere for Ovarian Cancer
FDA Approves Italfarmaco's Duvyzat (givinostat) for Duchenne Muscular Dystrophy
FDA Approves First Oral Drug for Duchenne Muscular Dystrophy by Italfarmaco
FDA Approves Italfarmaco's Duvyzat for All Genetic Variants of Duchenne MD
•Original version
FDA Approves Cabaletta Bio's CABA-201, Italfarmaco Group, and Duvyzat for Duchenne Muscular Dystrophy
